October 23, 2016 4:42 PM ET

Healthcare Equipment and Supplies

Company Overview of REVA Medical, Inc.

Company Overview

REVA Medical, Inc., a medical device company, focuses on the commercialization of minimally invasive medical devices for the treatment of conditions in the human body. It is developing and testing a drug-eluting bioresorbable stent to treat vascular disease in humans under the Fantom scaffold name. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.

5751 Copley Drive

San Diego, CA 92111

United States

Founded in 1998

61 Employees





Key Executives for REVA Medical, Inc.

Chief Executive Officer
Age: 57
Total Annual Compensation: $134.5K
President and Chief Operating Officer
Age: 59
Total Annual Compensation: $447.9K
Co-Founder and Director
Age: 62
Total Annual Compensation: $294.9K
Chief Financial Officer and Company Secretary
Age: 57
Total Annual Compensation: $373.1K
Senior Vice President of Clinical and Regulatory Affairs
Age: 49
Total Annual Compensation: $367.1K
Compensation as of Fiscal Year 2015.

REVA Medical, Inc. Key Developments

REVA Medical, Inc. Announces Resignation of Donald K. Brandom as Sr. Vice President of Product Development

On September 26, 2016, Donald K. Brandom, Sr. Vice President of Product Development, resigned from REVA Medical, Inc. effective immediately. The Company has no current plans to replace the position.

REVA Medical, Inc. Presents at 2016 InvestMNt Conference, Aug-23-2016 11:45 AM

REVA Medical, Inc. Presents at 2016 InvestMNt Conference, Aug-23-2016 11:45 AM. Venue: University of St. Thomas campus, Minneapolis, Minnesota, United States.

REVA Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016

REVA Medical, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the quarter, the company's loss from operations was $5,633,000 against $7,031,000 a year ago. Net income of and comprehensive income was $5,854,000 against loss of $4,555,000 a year ago. Net loss per common share - diluted was $0.12 against $0.11 a year ago. For the six months, the company's loss from operations was $10,486,000 against $14,512,000 a year ago. Net loss and comprehensive loss was $17,503,000 against $45,353,000 a year ago. Net loss per common share - diluted was $0.52 against $1.09 a year ago. Net cash used for operating activities was $9,437,000 against $11,404,000 a year ago. Purchases of property and equipment was $508,000 against $370,000 a year ago.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact REVA Medical, Inc., please visit www.revamedical.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.